From: Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
Adverse events
cyclophosphamide(%)
cyclosporine(%)
rituximab(%)
tacrolimus-rituximab(%)
References
minor infections
31
15
18
23
[17,18,19]
infusion-related reaction
2
0
34
7
pneumonia
9
3
gastrointestinal manifestation
19
6
28
leucopenia
38